Paper40343003
Multi-target neuroprotection by dl-PHPB in APP/PS1 mice: a proteomic analysis.
Sun Y and 6 others. Front Pharmacol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Multi-target neuroprotection by dl-PHPB in APP/PS1 mice: a proteomic analysis. Papers, record 40343003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40343003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29753086 | Applications of proteomics in pharmaceutical research and development. | Biochim Biophys Acta Proteins Proteom | 2019 | https://conductscience.org/library/papers/29753086 | PubMed |
| 2 | 31165206 | Protective effect of potassium 2-(l-hydroxypentyl)-benzoate on hippocampal neurons, synapses and dystrophic axons in APP/PS1 mice. | Psychopharmacology (Berl) | 2019 | https://conductscience.org/library/papers/31165206 | PubMed |
| 3 | 30050410 | The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain. | Front Cell Neurosci | 2018 | https://conductscience.org/library/papers/30050410 | PubMed |
| 4 | 31376433 | Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practice. | Pharmacol Ther | 2019 | https://conductscience.org/library/papers/31376433 | PubMed |
| 5 | 22002310 | Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis. | Oncogene | 2012 | https://conductscience.org/library/papers/22002310 | PubMed |
| 6 | 20835250 | ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticity. | Nat Neurosci | 2010 | https://conductscience.org/library/papers/20835250 | PubMed |
| 7 | 32500074 | Peptidyl-Prolyl Cis/Trans Isomerase Pin1 and Alzheimer's Disease. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32500074 | PubMed |
| 8 | 19667196 | Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19667196 | PubMed |
| 9 | 28752032 | Potassium 2-(l-hydroxypentyl)-benzoate attenuates neuroinflammatory responses and upregulates heme oxygenase-1 in systemic lipopolysaccharide-induced inflammation in mice. | Acta Pharm Sin B | 2017 | https://conductscience.org/library/papers/28752032 | PubMed |
| 10 | 15174014 | Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. | Ann Neurol | 2004 | https://conductscience.org/library/papers/15174014 | PubMed |
| 11 | 19561963 | Role of pyruvate dehydrogenase complex in traumatic brain injury and Measurement of pyruvate dehydrogenase enzyme by dipstick test. | J Emerg Trauma Shock | 2009 | https://conductscience.org/library/papers/19561963 | PubMed |
| 12 | 18184658 | Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18184658 | PubMed |
| 13 | 32941929 | Alzheimer's disease: Recent treatment strategies. | Eur J Pharmacol | 2020 | https://conductscience.org/library/papers/32941929 | PubMed |
| 14 | 38409216 | PHPB ameliorates memory deficits and reduces oxidative injury in Alzheimer's disease mouse model by activating Nrf2 signaling pathway. | Acta Pharmacol Sin | 2024 | https://conductscience.org/library/papers/38409216 | PubMed |
| 15 | 18334753 | Proteomic 2-D DIGE profiling of APP23 transgenic mice brain from pre-plaque and plaque phenotypes. | J Alzheimers Dis | 2008 | https://conductscience.org/library/papers/18334753 | PubMed |
| 16 | 11090625 | Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. | Mol Cell | 2000 | https://conductscience.org/library/papers/11090625 | PubMed |
| 17 | 12769185 | Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis--an approach for slowing Alzheimer disease? | J Neuropathol Exp Neurol | 2003 | https://conductscience.org/library/papers/12769185 | PubMed |
| 18 | 24893984 | Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease. | J Pharmacol Exp Ther | 2014 | https://conductscience.org/library/papers/24893984 | PubMed |
| 19 | 24908397 | Structure-guided simulations illuminate the mechanism of ATP transport through VDAC1. | Nat Struct Mol Biol | 2014 | https://conductscience.org/library/papers/24908397 | PubMed |
| 20 | 22337825 | Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence. | J Alzheimers Dis | 2012 | https://conductscience.org/library/papers/22337825 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40949132 | Systems pharmacology identifies ajugol-mediated NF-κB/caspase-3 inhibition and isoacteoside-driven p62/mTOR-mediated autophagy as key mechanisms of Rehmanniae Radix and its processed form in Alzheimer's treatment. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40949132 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40343003
GET https://conductscience.org/api/papers/v1/40343003/references?page=2